MPMarie Agnès Popot

Marie Agnès Popot

*This is an algorithmically generated author record based on publicly available information.

Marie Agnès Popot has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Analysis of iridoids from Harpagophytum and eleutherosides from Eleutherococcus senticosus in horse urine

    by C. Colas, M.‐A. Popot, P. Garcia, Y. Bonnaire, S. Bouchonnet

    LC/ESI‐MSn methods have been previously set up to detect the administration of (i) Harpagophytum and (ii) preparations containing a plant capable of anti‐stress properties: Eleutherococcus senticosus. Harpagoside has been found to be the main indicator of Harpagophytum administration in the horse. These methods have been applied to a large number of horse urine samples of various origins. Regarding the detection of Harpagophytum administration, harpagoside, harpagide and 8‐para‐coumaroyl harpagide were detected together in only one sample out of 317. Eleutheroside E was found to be the main indicator of Eleutherococcus senticosus administration. It was detected in post‐administration samples collected from two horses having received a feed supplement containing Eleutherococcus senticosus for several days. Out of the 382 samples tested, eleutheroside E was found in an unexpected large number of urine samples (39%) of various origins and its presence cannot be only due to the sole use of herbal dietary supplements. Copyright © 2008 John Wiley & Sons, Ltd.


  • Boldenone, testosterone and 1,4‐androstadiene‐3,17‐dione determination in faeces from horses, untreated and after administration of androsta‐1,4‐diene‐3,17‐dione (boldione)

    by M. A. Popot, S. Boyer, L. Menaut, P. Garcia, Y. Bonnaire, D. Lesage

    Faeces, which could be a potential alternative medium for doping control, have been used for the detection of 1,4‐androstadiene‐3,17‐dione administration to the horse. Semi‐quantitative analyses of 1,4‐androstadiene‐3,17‐dione, testosterone, 17α‐ and 17β‐boldenone have been conducted in pre‐ and post‐administration faeces, and in controls (untreated stallions, geldings and mares). Sample preparation comprised diethyl ether extraction, lipid removal, HPLC purification and derivatisation. 1,4‐Androstadiene‐3,17‐dione, testosterone, 17α‐ and 17β‐boldenone were analysed by GC‐EI/MS/MS. Quantitative limits of detection were 0.1 ng/g for 1,4‐androstadiene‐3,17‐dione, and 0.025 ng/g for testosterone, 17α‐ and 17β‐testosterone. In post‐administration samples from geldings and mares, peak levels of 1,4‐androstadiene‐3,17‐dione, 17α‐, 17β‐boldenone and testosterone were attained 24 h after administration. In untreated geldings and mares (in di‐ or anoestrus), 17α‐ and 17β‐boldenone and testosterone were not detected. Faeces from females in oestrus had detectable levels of boldenone isomers and testosterone. 1,4‐Androstadiene‐3,17‐dione was undetectable in faeces collected from untreated horses, but the presence of this androgen was recently reported in faeces from untreated swine and it would therefore be advisable to check for its possible presence in a larger number of individual faecal samples. Copyright © 2008 John Wiley & Sons, Ltd.


  • Determination of IGF-I in horse plasma by LC electrospray ionisation mass spectrometry

    by Marie-Agnes Popot, Adrian R. Woolfitt, Patrice Garcia, Jean-Claude Tabet

    The insulin-like-growth factor (IGF-I) peptide is considered to be the main indirect marker for growth hormone administration (GH) in a horse. Further to a previous investigation on measurement of IGF-I in plasma samples by mass spectrometry, this study focuses on quantitative and qualitative analysis of intact IGF-I in horse plasma. First, protein-transposing software has been developed for IGF-I to facilitate its quantification by HPLC–electrospray–ion-trap mass spectrometry. Second, product-ion scan experiments on IGF-I have been conducted on standard samples, non-fortified equine plasma samples, fortified plasma samples, and equine GH post-administration samples. This “top-down” approach method enables characterisation of fragment ions corresponding to the carboxy terminal end, which can be useful for the confirmation of the presence of IGF-I in plasma samples. Structure of IGF-I and amino acid sequences of IGF-I and R3 IGF-I. Deconvolution mass spectra of the IGF-I and R3 IGF-I mixture


  • Open Access

    Optimization of solid-phase extraction for the liquid chromatography-mass spectrometry analysis of harpagoside, 8-para-coumaroyl harpagide, and harpagide in equine plasma and urine.

    by Cyril Colas, Patrice Garcia, Marie-AgnÈS Popot, Yves Bonnaire, StÉPhane Bouchonnet

    Solid-phase extraction cartridges among those usually used for screening in horse doping analyses are tested to optimize the extraction of harpagoside (HS), harpagide (HG), and 8-para-coumaroyl harpagide (8PCHG) from plasma and urine. Extracts are analyzed by liquid chromatography coupled with multi-step tandem mass spectrometry. The extraction process retained for plasma applies BondElut PPL cartridges and provides extraction recoveries between 91% and 93%, with RSD values between 8 and 13% at 0.5 ng/mL. Two different procedures are needed to extract analytes from urine. HS and 8PCHG are extracted using AbsElut Nexus cartridges, with recoveries of 85% and 77%, respectively (RSD between 7% and 19%). The extraction of HG involves the use of two cartridges: BondElut PPL and BondElut C18 HF, with recovery of 75% and RSD between 14% and 19%. The applicability of the extraction methods is determined on authentic equine plasma and urine samples after harpagophytum or harpagoside administration.


  • Detection of testosterone propionate administration in horse hair samples

    by S. Boyer, P. Garcia, M.A. Popot, V. Steiner, M. Lesieur


  • Liquid chromatography/electrospray ionization mass spectrometric characterization of Harpagophytum in equine urine and plasma

    by Cyril Colas, Patrice Garcia, Marie‐Agnès Popot, Yves Bonnaire, Stéphane Bouchonnet

    A method has been developed for the analysis and characterization in equine urine and plasma of iridoid glycosides: harpagide, harpagoside and 8‐ para ‐coumaroyl harpagide, which are the main active principles of Harpagophytum , a plant with antiinflammatory properties. The method involves liquid chromatography coupled with positive electrospray ionization mass spectrometry. The addition of sodium or lithium chloride instead of formic acid in the eluting solvent has been studied in order to enhance the signal and to modify the ion's internal energy. Fragmentation pathways and associated patterns are proposed for each analyte. A comparison of three types of mass spectrometer: a 3D ion trap, a triple quadrupole and a linear ion trap, has been conducted. The 3D ion trap was selected for drug screening analysis whereas the linear ion trap was retained for identification and quantitation analysis. Copyright © 2006 John Wiley & Sons, Ltd.


  • Open Access

    Use of accelerating solvent extraction for detecting non-steroidal anti-inflammatory drugs in horse feces.

    by M. A. Popot, A. Donval, Y. Bonnaire, J. Huau

    Feces are a possible medium to be used for horse doping control. Efficient methods for detecting drugs in feces collected from various animals are routinely applied in institutes of food safety in Belgium. We have already tested whether they are applicable to horse feces. In this report, accelerated solvent extraction (ASE), an efficient method for extracting compounds from solid material, has been tested. ASE has been used to replace the diethyl ether liquid-liquid extraction step present in the method initially set up. This technique has been optimized for detecting several non-steroidal anti-inflammatory drugs (NSAIDs) in horse feces. Extraction recovery and limit of detection have been determined for several NSAIDs, such as meclofenamic acid, flunixin, vedaprofen, celecoxib, carprofen, diclofenac, and ketoprofen. The method has been successfully applied to meclofenamic acid, flunixin, and phenylbutazone post-administration feces samples, and the main metabolites identified in urine were also detected in feces. In the case of meclofenamic acid, the detection profile in feces presented in this report is in accordance with our previous finding in feces obtained with the original method. The use of ASE decreases the time necessary for sample preparation. This method is applicable on a large scale, which is useful for horse doping control.


  • First mass spectrometric detection of boldenone in horse mane samples

    by M. A. Popot, N. Stojiljkovic, P. Garcia, Y. Bonnaire, J. C. Tabet


  • Gas‐phase behaviour of negative ions produced from thiazidic diuretics under electrospray conditions

    by Patrice Garcia, Marie Agnès Popot, Françoise Fournier, Yves Bonnaire, Jean Claude Tabet

    A systematic mass spectrometric study of 10 thiazidic diuretics and related compounds was undertaken by mass spectrometry (MS) with electrospray ionization in the negative ion mode. Collisional dissociation ‘in‐source’ (CID‐MS) and in a low‐pressure collision cell (CID‐MS/MS) were compared in both excitation regions. Spectra obtained by CID‐MS and by CID‐MS/MS were matched. Using the two methods, loss of HCl and consecutive dissociations from 2HCl losses were exhibited from compounds such as methyclothiazide and trichlormethiazide but not from other thiazidic diuretics that contain chlorine substituents in the aromatic moiety. However, deprotonated dichlorphenamide gave rise to loss of HCl by CID‐MS and CID‐MS/MS. For other diuretics such as hydroflumethiazide and hydrochlorothiazide, the loss of HCN and [HCN + SO2] was relevant. Reaction mechanisms were checked by means of deuterium–hydrogen exchange, which showed that deprotonation took place regioselectively on the heterocyclic moiety. The cleavage pathways require molecular isomerization forming ion–dipole complexes prior to decompositions, allowing long‐distance proton transfer for neutral elimination. Identifications of the most specific fragmentations presented in this paper were applied to the screening and unambiguous identification of diuretics for horse doping control. Copyright © 2002 John Wiley & Sons, Ltd.